Activist Investing
  • About The Principal
  • Investment Philosophy
  • In The News
  • Distressed and Special Situations Investing
  • Blog
  • Contact
  • Privacy policy & Terms of Use
     
    Activist Investing
      • About The Principal
      • Investment Philosophy
      • In The News
      • Distressed and Special Situations Investing
      • Blog
      • Contact
      • Privacy policy & Terms of Use

      In The News


      Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership

      Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership

      Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar

      Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar

      LQR House Inc. Announces Change of Ticker Symbol From "LQR" to "YHC" Effective December 16, 2024

      LQR House Inc. Announces Change of Ticker Symbol From "LQR" to "YHC" Effective December 16, 2024

      Activist investor David Lazar to invest $3M in LQR House

      Activist investor David Lazar to invest $3M in LQR House

      David E. Lazar Announces Ownership Interest in Minim, Inc.

      David E. Lazar Announces Ownership Interest in Minim, Inc.

      Titan Pharmaceuticals Shares Double on Reverse Merger Deal

      Titan Pharmaceuticals Shares Double on Reverse Merger Deal

      Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.

      Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.

      Activist Investing Discloses 9.9% Ownership Interest in Titan Pharmaceuticals, Inc.

      Activist Investing Discloses 9.9% Ownership Interest in Titan Pharmaceuticals, Inc.

      Lionel Messi’s fashion royalties and shipping’s road to Nasdaq

      Lionel Messi’s fashion royalties and shipping’s road to Nasdaq

      OpGen Announces Acquisition of Preferred Stock by David Lazar

      OpGen Announces Acquisition of Preferred Stock by David Lazar

      No Product, No Sales, No Prospects? Consider a Reverse Merger

      No Product, No Sales, No Prospects? Consider a Reverse Merger

      Minim Rises After Investor David Lazar Buys 2M Preferred Shares

      Minim Rises After Investor David Lazar Buys 2M Preferred Shares

      • 1
      • 2
      • 3
      • »
      Activist Investing
      Copyright © 2025 All rights reserved
      Terms    |    Privacy    
      • Home
      • About The Principal
      • Investment Philosophy
      • In The News
      • Distressed and Special Situations Investing
      • Blog
      • Contact
      • Privacy policy & Terms of Use
       
      •  
      •  
       
      •  
      •  
      •  +1-646-768-8417
      •   david@activistinvestingllc.com
      •   5305 Vida Marina, Dubai, U.A.E.
      • Google Maps
      • Waze
      • Moovit
      • Moovit
      •  
      •